Medicare and patient spending among beneficiaries diagnosed with chronic myelogenous leukemia
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32137
Abstract: The authors examined Medicare spending and patient spending in older patients with chronic myelogenous leukemia (CML) over the first 5 years from the time of CML diagnosis in the tyrosine kinase inhibitor (TKI) era. read more here.
Keywords: patient spending; medicare patient; chronic myelogenous; myelogenous leukemia ... See more keywords